Lamdong Pharmaceutical JSC (HNX: LDP)
Vietnam
· Delayed Price · Currency is VND 9,800.00
-100.00 (-1.01%)
At close: Jan 24, 2025
HNX: LDP Income Statement
Financials in millions VND. Fiscal year is January - December.
Millions VND. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2019 | FY 2018 | 2017 - 2013 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | 2017 - 2013 |
| Revenue | 191,496 | 186,001 | 187,415 | 161,902 | 379,664 | 431,851 | Upgrade
|
| Revenue Growth (YoY) | 1.95% | -0.75% | 15.76% | -57.36% | -12.08% | -18.26% | Upgrade
|
| Cost of Revenue | 141,410 | 148,835 | 149,895 | 140,678 | 303,243 | 373,666 | Upgrade
|
| Gross Profit | 50,087 | 37,166 | 37,519 | 21,225 | 76,420 | 58,186 | Upgrade
|
| Selling, General & Admin | 48,060 | 49,509 | 62,833 | 41,013 | 78,898 | 71,021 | Upgrade
|
| Operating Expenses | 48,060 | 49,509 | 62,833 | 41,013 | 78,898 | 71,021 | Upgrade
|
| Operating Income | 2,027 | -12,343 | -25,314 | -19,788 | -2,477 | -12,835 | Upgrade
|
| Interest Expense | -7,300 | -7,027 | -7,544 | -2,210 | -5,987 | -4,702 | Upgrade
|
| Interest & Investment Income | 398.42 | 846.07 | 2,862 | 31,615 | 617.9 | 644.73 | Upgrade
|
| Other Non Operating Income (Expenses) | -1,201 | -1,581 | -8,851 | 31,105 | 21,814 | 35.22 | Upgrade
|
| Pretax Income | -6,075 | -20,105 | -38,848 | 40,721 | 13,967 | -16,857 | Upgrade
|
| Income Tax Expense | - | - | 43.69 | 2,850 | 4,382 | 13.3 | Upgrade
|
| Net Income | -6,075 | -20,105 | -38,891 | 37,870 | 9,586 | -16,870 | Upgrade
|
| Net Income to Common | -6,075 | -20,105 | -38,891 | 37,870 | 9,586 | -16,870 | Upgrade
|
| Net Income Growth | - | - | - | 295.07% | - | - | Upgrade
|
| Shares Outstanding (Basic) | 13 | 13 | 13 | 13 | 8 | 8 | Upgrade
|
| Shares Outstanding (Diluted) | 13 | 13 | 13 | 13 | 8 | 8 | Upgrade
|
| Shares Change (YoY) | 0.04% | -0.01% | -0.02% | 62.22% | 0.04% | -0.01% | Upgrade
|
| EPS (Basic) | -477.99 | -1583.00 | -3062.00 | 2981.00 | 1224.00 | -2155.00 | Upgrade
|
| EPS (Diluted) | -477.99 | -1583.00 | -3062.00 | 2981.00 | 1224.00 | -2155.00 | Upgrade
|
| EPS Growth | - | - | - | 143.55% | - | - | Upgrade
|
| Free Cash Flow | 15,671 | 5,709 | -46,718 | 21,392 | 1,132 | 971.57 | Upgrade
|
| Free Cash Flow Per Share | 1232.99 | 449.54 | -3678.26 | 1683.88 | 144.57 | 124.11 | Upgrade
|
| Gross Margin | 26.16% | 19.98% | 20.02% | 13.11% | 20.13% | 13.47% | Upgrade
|
| Operating Margin | 1.06% | -6.64% | -13.51% | -12.22% | -0.65% | -2.97% | Upgrade
|
| Profit Margin | -3.17% | -10.81% | -20.75% | 23.39% | 2.52% | -3.91% | Upgrade
|
| Free Cash Flow Margin | 8.18% | 3.07% | -24.93% | 13.21% | 0.30% | 0.22% | Upgrade
|
| EBITDA | 9,344 | -4,106 | -16,414 | -8,047 | 6,384 | -2,089 | Upgrade
|
| EBITDA Margin | 4.88% | -2.21% | -8.76% | -4.97% | 1.68% | -0.48% | Upgrade
|
| D&A For EBITDA | 7,316 | 8,237 | 8,900 | 11,742 | 8,861 | 10,746 | Upgrade
|
| EBIT | 2,027 | -12,343 | -25,314 | -19,788 | -2,477 | -12,835 | Upgrade
|
| EBIT Margin | 1.06% | -6.64% | -13.51% | -12.22% | -0.65% | -2.97% | Upgrade
|
| Effective Tax Rate | - | - | - | 7.00% | 31.37% | - | Upgrade
|
| Revenue as Reported | 191,496 | 186,001 | 187,415 | 161,902 | 379,664 | 431,851 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.